The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics.
about
Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugsAdherence and drug resistance: predictions for therapy outcome"One-size-fits-all"? Optimizing treatment duration for bacterial infectionsImproving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsIntegrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentOptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensQuantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling.The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteriaPharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Regulating the use of antibiotics in the community.Mathematical modeling of malaria infection with innate and adaptive immunity in individuals and agent-based communities.P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model.Intrahost modeling of artemisinin resistance in Plasmodium falciparumThe evolution of drug-resistant malaria: the role of drug elimination half-lifeLink between immune response and parasite synchronization in malariaDevelopment, evaluation, and application of an in silico model for antimalarial drug treatment and failure.Dynamics of immune response and drug resistance in malaria infection.Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.A stochastic model of immune-modulated malaria infection and disease in children.Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug TreatmentOn the role of resonance in drug failure under HIV treatment interruption.Quantifying the pharmacology of antimalarial drug combination therapy.Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough?Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials.Exploring the role of the immune response in preventing antibiotic resistance.Problems with continuous-time malaria models in describing gametocytogenesis.Development of a population simulation model for HIV monotherapy virological outcomes using lamivudine.A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.Synchronous versus asynchronous oscillations for antigenically varying Plasmodium falciparum with host immune response.Mathematical modelling of the antibiotic-induced morphological transition of Pseudomonas aeruginosa.Top-down or bottom-up regulation of intra-host blood-stage malaria: do malaria parasites most resemble the dynamics of prey or predator?
P2860
Q27025529-BB669016-BCF8-4A46-AF6C-5EDE063CAC87Q27477742-616B76EB-D0D8-45E2-8E2F-4B319E85FD70Q28478851-8276CBE0-0D60-40AB-B8C1-1AD5E8B42BB5Q28534701-4CA26D83-31E4-4A73-B379-BA5685CEA877Q28551361-33FAEF99-6F4F-4DA8-BCB0-FACA343A1CECQ28831110-2A577192-6D10-40DD-ADA6-53D67DF60EBCQ30892194-13742A04-DA7C-4415-86DA-F76A7DF5E150Q33396218-F08F8CC4-0DC2-4896-8F0D-FEEBE3994A41Q33555316-2CF78E39-E505-4A53-BB0C-D87CD18EDC75Q33678483-162946B7-29ED-4B7A-93A1-949171DA06D0Q33791803-329FCBCE-BB95-40A8-AFFE-2918FB37C223Q34217648-6204990C-5782-4774-AEDD-8C38F0ECFFD7Q34427744-F40DFB38-A865-4285-BB3F-9CC2515667EDQ34471842-3B059366-C36E-447D-B92E-77ABA5121A55Q34655810-B6499BA3-90E3-4DD6-B0DA-0D79D2DF10CFQ34870862-4A7A19E6-9836-4FF4-BA3B-8FF3ECD017C0Q35065737-D964B007-4383-4576-B810-2D9862A26928Q35118887-8DB1A2BB-216A-4825-81F1-75E773C4F3A2Q35212401-62DF00F6-927A-4532-BE64-DCFAD3DFF887Q36325249-4141BFB1-0AB9-4663-B18F-C817F2BAE1D2Q36505504-BB29B7FB-15C7-4AC4-A61F-CE64353E76ABQ36888028-5ED3963F-36CA-41E7-A5C0-80D277813457Q37033475-55F1C98F-415D-440D-A202-7629222C0B74Q37283299-FC07BD61-F62E-4A40-A89A-FA698904DCC4Q37685088-A3A5BC19-9A79-40B7-8350-7FF4BD61E698Q38225084-69255C7C-0816-483A-A57F-920D315DEE79Q44028719-4E3F29FB-421B-495B-98A8-430C8B730314Q44141909-53434BB6-52BA-47EC-951B-863032CB6601Q45090413-96B03B44-A1B6-4C23-A98A-2E711D9FED19Q47100908-C29412CE-869C-42AE-BC75-F9A36781A084Q48016859-60EE0261-B0F2-4A5E-BAE1-677A643D621AQ51738032-2BF7B7BB-6FE9-4EB6-9AB6-5C685B353248Q55209095-6ABB40FA-2DA2-4C0D-BA82-FDD2506639C7
P2860
The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
The dynamics of drug action on ...... pathogen population dynamics.
@en
The dynamics of drug action on ...... pathogen population dynamics.
@nl
type
label
The dynamics of drug action on ...... pathogen population dynamics.
@en
The dynamics of drug action on ...... pathogen population dynamics.
@nl
prefLabel
The dynamics of drug action on ...... pathogen population dynamics.
@en
The dynamics of drug action on ...... pathogen population dynamics.
@nl
P356
P1476
The dynamics of drug action on ...... pathogen population dynamics.
@en
P2093
Anderson RM
P304
P356
10.1006/JTBI.1997.0438
P407
P577
1998-10-01T00:00:00Z